Mangalam Drugs And Organics Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
MANGALAM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mangalam Drugs & Organics has informed the stock exchanges that its trading window will remain closed starting July 1, 2025, until 48 hours after the company declares its unaudited financial results for the quarter ending June 30, 2025 (Q1 FY26). During this period, designated persons, including their immediate relatives, are prohibited from trading in the company's shares. This is a standard compliance requirement under SEBI's Insider Trading Regulations, 2015. The closure signals that the company is approaching its first-quarter earnings announcement.
This is a routine regulatory filing and has no direct impact on the stock price. However, it indicates that Q1 FY26 results are due soon, which may serve as a near-term catalyst for the stock depending on the numbers declared.